← Eichor
Study identifier: NCT07045259 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Exergaming Program Versus Neuromuscular Exercise in Elderly People With Motor Cognitive Risk Syndrome

Condition: Motoric Cognitive Risk Syndrome · Elderly (People Aged 65 or More) · Geriatric Patient  ·  Sponsor: Istanbul University - Cerrahpasa

PhaseNA
Planned participants60
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

The primary aim of our study is to compare the effects of neuromuscular exercise training versus structured exergaming program on locomotor and cognitive functions in elderly individuals with Motor Cognitive Risk (MCR), which defines the transition state between typical aging and dementia and mild cognitive impairment. This study aims to present for the first time the effects of neuromuscular exercise training and exergaming program on locomotor and cognitive functions in elderly individuals with MCR with comparative results.

This description comes directly from the study's public registry record.

Talk to the study team

GULFİDAN TOKGÖZ, Lecturer, PhD (c)  ·  +90552 022 76 32  ·  gulfidan.tokgoz@gmail.com

Saime Nilay ARMAN, Assoc. Prof. Dr.  ·  +90553 455 87 07  ·  saimenilayarman@istanbul.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Balıkesir ÜniversitesiBalıkesir, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07045259